Patient-reported outcomes (PROs) report patients’ assessments of the impact of a health
condition and its treatment, and can promote patient-centered care. Objectives To address the …

Introduction There are concerns that hydrochlorothiazide may increase the risk of incident
nonmelanoma (cutaneous squamous cell carcinoma [cSCC], basal cell carcinoma [BCC]) and …

OBJECTIVE There are uncertainties regarding the association between dipeptidyl peptidase
4 (DPP-4) inhibitors and bullous pemphigoid (BP), a potentially severe autoimmune skin …

Purpose This study assessed the uptake of the CONsolidated Standards of Reporting Trials
(CONSORT)—Patient-Reported Outcomes (PRO) statement; determined if use of CONSORT…

Objectives To describe the prescribing trends of antihypertensive drugs in primary care patients
and assess the trajectory of antihypertensive drug prescriptions, from first-line to third-line…

Background: With many disease-modifying therapies currently approved for the management
of multiple sclerosis, there is a growing need to evaluate the comparative effectiveness …

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder that may be treated with
non-ablative light-based devices; however, no systematic reviews on the topic exist to date…

Background Propensity score (PS) methods are frequently used in cardiovascular clinical
research. Previous evaluations revealed poor reporting of PS methods, however a …

Purpose Peer review (PR) of treatment plans has been recognized internationally as a key
component of quality care in radiation oncology programs (ROPs). We conducted a survey of …

Purpose Although health-related quality of life (HRQL) is increasingly assessed in randomized
controlled trials (RCTs), HRQL findings are not always incorporated into clinical decision …